Bensali, Ashyana S.

HRN: 27-82-43  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/26/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
09/26/2025
10/03/2025
IV
50mg
Q12
PCAP
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines